Florida’s top health official said on March 7 the state would recommend against the COVID-19 vaccine for healthy children, breaking with guidance from the U.S. Centers for Disease Control and Prevention.
COVID-19 Update: Omicron BA.2 Raises Questions, FDA Limits GSK Antibody
BNT162b2 (Pfizer and BioNTech), CDC, Clinical Trials, Coronavirus Cases, Covid-19 Data, COVID-19 Studies, COVID-19 Vaccinations, FDA, GlaxoSmithKline, Monoclonal Antibodies, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Multisystem Inflammatory Syndrome in children (MIS-C), Omicron (B.1.1.529) (South Africa), Omicron BA.2, R&D, Sotrovimab, Teenagers, Vir BiotechnologyThe BA.2 subvariant of Omicron, which appears to be even more transmissible than Omicron, is accounting for more than a third of global COVID-19 cases. In other news, the U.S. Food and Drug Administration placed limits on the use of GlaxoSmithKline and Vir Biotechnology’s COVID-19 antibody therapeutic, sotrovimab.
Two doses of the Pfizer Inc. and BioNTech SE COVID-19 vaccine are highly protective against a rare but often serious condition in children that causes organ inflammation weeks after COVID-19 infections, a U.S. Centers for Disease Control and Prevention report said on January 7.
Beckman Coulter will be using a grant from BARDA (the Biomedical Advanced Research and Development Authority, a division of the Dept. of Health and Human Services) to validate the ability of the company’s Monocyte Distribution Width (MDW) hematology biomarker to aid in the rapid detection of a rare but serious complication of Covid-19 affecting children.